Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial

Autor: Shore, Neal, Gazi, Mukaram, Pieczonka, Christopher, Heron, Sean, Modh, Rishi, Cahn, David, Belkoff, Laurence H., Berger, Aaron, Mazzarella, Brian, Veys, Joseph, Idom, Charles, Morris, David, Jayram, Gautam, Engelman, Alexander, Bukkapatnam, Raviender, Dato, Paul, Bevan-Thomas, Richard, Cornell, Robert, Wise, David R., Hardwick, Mary Kay, Hernandez, Ryan D., Rojahn, Susan, Layman, Paige, Hatchell, Kathryn E., Heald, Brandie, Nussbaum, Robert L., Nielsen, Sarah M., Esplin, Edward D.
Zdroj: In European Urology Oncology October 2023 6(5):477-483
Databáze: ScienceDirect
Externí odkaz: